CARDIFF ONCOLOGY, INC. Public Float
CARDIFF ONCOLOGY, INC. (CRDF) had Public Float of $205.40 million as of 2025-06-30, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-24
- 2025-06-30: Entity Public Float $205.40M.
- 2024-06-30: Entity Public Float $99.10M.
- 2023-06-30: Entity Public Float $64.34M.
- 2022-06-30: Entity Public Float $93.82M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $205.40M 10-K · filed 2026-02-24 |
| 2024-06-30 | $99.10M 10-K · filed 2025-02-27 |
| 2023-06-30 | $64.34M 10-K · filed 2024-02-29 |
| 2022-06-30 | $93.82M 10-K · filed 2023-03-02 |
| 2021-06-30 | $258.94M 10-K · filed 2022-02-24 |
| 2020-06-30 | $103.72M 10-K · filed 2021-02-25 |
| 2019-06-30 | $13.55M 10-K · filed 2020-02-27 |
| 2018-06-30 | $13.22M 10-K · filed 2019-03-06 |
| 2017-06-30 | $38.26M 10-K · filed 2018-02-26 |
| 2016-06-30 | $118.69M 10-K · filed 2017-03-15 |
| 2015-06-30 | $195.68M 10-K · filed 2016-03-10 |
| 2014-06-30 | $63.97M 10-K · filed 2015-03-12 |
| 2013-06-28 | $100.38M 10-K · filed 2014-03-17 |
| 2012-06-29 | $51.73M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |